Abstract:You have accessJournal of UrologyBenign Prostatic Hyperplasia: Medical & Hormonal Therapy1 Apr 2014PD23-01 INHIBITOR OF 5A-REDUCTASE TYPES II PROMOTES THE INFILTRATION OF CD8+T CELLS IN BPH TISSUES. Yu Fan, Shuai Hu, Wei Yu, Qian Zhang, and Jie Jin Yu FanYu Fan More articles by this author , Shuai HuShuai Hu More articles by this author , Wei YuWei Yu More articles by this author , Qian ZhangQian Zhang More articles by this author , and Jie JinJie Jin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.1838AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Early clinical studies suggested male sex hormones might be associated with infiltrating T cells in benign prostatic hyperplasia (BPH) patients, but the detail of which T cell subset and mechanism still remained unclear. The present study tested the hypothesis that inhibitor of 5a-reductase types II exerts effects on the T cells infiltration in BPH tissues during the treatment process. METHODS Prostate tissues from cases of BPH patients after TURP were divided into 2 groups: 1. No medication history; 2. Inhibitor of 5a-reductase types II (finasteride 5mg daily) for at least 6 months before surgery. Immunohistochemistry and flow cytometry were used for CD4 and CD8 staining. Then isolated the normal T cell from blood of health persons and detected the T cell migration capability induced by prostate tissue lysates from different groups. In vitro co-culture system was also used to detect the CD8+T cell-line (Molt-3) recruited by BPH-1 cells in condition of androgen deprivation. T cell related chemokines and receptors were evaluated by q-PCR and confirmed in clinical samples by IHC staining. RESULTS CD8+T cells were showed more infiltration in BPH tissue after inhibitor of 5a-reductase types II treatment, however CD4+T cells showed no changes. The prostate tissue lysates from group 2 were found a better capacity than group 1 to recruit CD8+ T cells from health persons. Then in vitro study, BPH-1 cells could recruit more Molt-3 cells after androgen deprivation via secreting more chemokine-CCL5 and CCR5 up-regulation in BPH-1 cells. These data was also identified in above 2 groups of prostate tissues. CONCLUSIONS Inhibitor of 5a-reductase types II treated prostate tissue showed increased CD8+T cell infiltration. These findings suggest that different androgen level by means of inhibitor of 5a-reductase types II treatment may interfere with the inflammatory reaction in BPH tissues. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e666 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Yu Fan More articles by this author Shuai Hu More articles by this author Wei Yu More articles by this author Qian Zhang More articles by this author Jie Jin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

[Expression and Significance of Steroid 5Alpha-Reductase Isoenzymes in Benign Hyperplastic Prostate Tissues].

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

Expressions of Shh and Stathmin in Prostatic Diseases and Their Clinical Significances

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study

PD23-01 INHIBITOR OF 5A-REDUCTASE TYPES II PROMOTES THE INFILTRATION OF CD8+T CELLS IN BPH TISSUES.

Correlation study on the expression of transforming growth factor-β type I receptor and fibrohlast growth factor type I receptor in BPH

[Natural 5Α-Reductase Inhibitors in Treatment of Benign Prostatic Hyperplasia].

Associated study on expression of androgen receptor and type Ⅰ transforming growth factor- β receptor in BPH

Expression and Significance of Estrogen Receptor Α and Β in Prostate Cancer and Peri-Cancer Tissue

Expression Characteristics of 5α-reductase Type Ⅱ in Epididymal Cell Lines PC1 and DC2

Expression ofαs1-casein in benign prostatic hyperplasias

The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH

Expression of αs1-casein in benign prostatic hyperplasias

The Role of 5α-Reductase in Prostate Disease and Male Pattern Baldness

EXPRESSION OF Bcl-2 Mrna IN NORMAL AND HYPERPLASTIC PROSTATE TISSUES

Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia

Inhibition Of Androgen Induces Autophagy In Benign Prostate Epithelial Cells

Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates